This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.

Click here and I’ll tell you everything you need to know.

George Fennell Biography and Net Worth

SVP of IDEXX Laboratories

Mr. Fennell has been Senior Vice President of IDEXX since January 2020 and was a Corporate Vice President from June 2011 to January 2020. He has served as our Chief Revenue Officer since January 2024, and in this role, he leads our global commercial sales and field support teams. Prior to becoming our Chief Revenue Officer, Mr. Fennell led the Companion Animal Group Customer Facing Organization in the Americas and Europe from May 2023 to December 2023 and the North American Companion Animal Group Customer Facing Organization from June 2011 to May 2023. Prior to joining IDEXX in 2011, Mr. Fennell worked at Pfizer Animal Health, a division of Pfizer Inc., the world’s largest research-based pharmaceutical company, where in April 2003 he began as head of marketing for the companion animal business. He then served as vice president of the U.S. Companion Animal Division from 2005 through 2010, and from January 2011, was Vice President, Pfizer Animal Genetics, Diagnostics and Aquaculture. Before his tenure at Pfizer, he held a series of sales, marketing and operational roles in the crop sciences business for American Cyanamid and BASF, diversified chemical companies. Mr. Fennell holds a bachelor’s degree in economics and agricultural business from the University of Delaware.

What is George Fennell's net worth?: The estimated net worth of George Fennell is at least $2.81 million as of February 8th, 2024. Mr. Fennell owns 6,712 shares of IDEXX Laboratories stock worth more than $2,809,710 as of November 21st. This net worth approximation does not reflect any other assets that Mr. Fennell may own. Learn More about George Fennell's net worth.
How old is George Fennell?: Mr. Fennell is currently 55 years old. There are 5 older executives and no younger executives at IDEXX Laboratories. The oldest executive at IDEXX Laboratories is Mr. Jonathan J. Mazelsky, President, CEO & Director, who is 63 years old. Learn More on George Fennell's age.
How do I contact George Fennell?: The corporate mailing address for Mr. Fennell and other IDEXX Laboratories executives is ONE IDEXX DRIVE, WESTBROOK ME, 04092. IDEXX Laboratories can also be reached via phone at (207) 556-0300 and via email at [email protected]. Learn More on George Fennell's contact information.
Has George Fennell been buying or selling shares of IDEXX Laboratories?: George Fennell has not been actively trading shares of IDEXX Laboratories during the last quarter. Most recently, George Fennell sold 8,198 shares of the business's stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $573.87, for a transaction totalling $4,704,586.26. Following the completion of the sale, the senior vice president now directly owns 6,712 shares of the company's stock, valued at $3,851,815.44. Learn More on George Fennell's trading history.
Who are IDEXX Laboratories' active insiders?: IDEXX Laboratories' insider roster includes Jonathan Ayers (Director), Bruce Claflin (Director), George Fennell (SVP), Rebecca Henderson (Director), Nimrata Hunt (EVP), Daniel Junius (Director), Michael Lane (EVP), Jonathan Mazelsky (CEO), Brian Mckeon (CFO), James Polewaczyk (EVP), M. Szostak (Director), Kathy Turner (SVP), Kathy Turner (SVP), Giovani Twigge (SVP), and Sophie Vandebroek (Director). Learn More on IDEXX Laboratories' active insiders.
Are insiders buying or selling shares of IDEXX Laboratories?: During the last year, insiders at the sold shares 6 times. They sold a total of 62,488 shares worth more than $34,708,688.36. The most recent insider tranaction occured on May, 17th when Director Bruce L Claflin sold 200 shares worth more than $108,160.00. Insiders at IDEXX Laboratories own 2.1% of the company. Learn More about insider trades at IDEXX Laboratories.
Information on this page was last updated on 5/17/2024.

George Fennell Insider Trading History at IDEXX Laboratories

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
2/8/2024	Sell	8,198	$573.87	$4,704,586.26	6,712

George Fennell Buying and Selling Activity at IDEXX Laboratories

IDEXX Laboratories Company Overview

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Today's Range

Now: $418.61

$410.29

$419.41

50 Day Range

MA: $464.08

$406.92

$517.06

2 Week Range

Now: $418.61

$404.74

$583.39

Volume

650,295 shs

Average Volume

775,549 shs

Market Capitalization

$34.28 billion

P/E Ratio

40.37

Dividend Yield

N/A

Beta

1.36

Missed Nvidia? Watch this ASAP

From Brownstone Research | Ad